Phreesia (PHR) Stock: Buy, Sell, or Hold?
PHR - Phreesia, Inc.
$12.72
0.46 (3.75%)
▲
5d:
+15.22%
30d:
+31.4%
90d:
+24.46%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Dec 14, 2026
Get Alerted When PHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PHR is 12.7% above its trading range ($11.29). Market expects -1.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PHR is 12.7% above its trading range ($11.29). Market expects -1.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$25.81
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.02
20.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHR is currently trading at $12.72, which is considered extended relative to its 30-day fair value range of $9.90 to $11.29. The stock's valuation (Forward PE: 8.4) is in line with its historical norms (8.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This pessimistic expectation contrasts with the company's recent 200% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHR is in a uptrend. The price is approaching resistance at $12.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: PHR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHR is in a uptrend. The price is approaching resistance at $12.73. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: PHR scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.90 -
$11.29
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
34.6%
Protect Your Profits
PHR is technically overbought (RSI 76). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.7% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- NEUTRAL: Near Wall St target ($13.93)
- WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.90 -
$11.29
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.80
(6.3%)
Support & Resistance Levels
Support Level
$10.49
Resistance Level
$12.73
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.45
Wall Street Target
$13.93
(+9.5%)
Revenue Growth (YoY)
10.4%
Earnings Growth (YoY)
200.0%
Profit Margin
2.1%
Valuation Discount vs History
-1.2% cheaper
PE vs Historical
8.5 vs 8.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.2%
(market-implied from PE analysis)
1-Year Target
$12.57
(-1%)
2-Year Target
$12.42
(-2%)
3-Year Target
$12.27
(-4%)
3-Yr Target (if PE normalizes)
(PE: 8→9)
$12.78
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 29.2%)
$64.43
(+407%)
Base:
(SPY PE: 8.4, Growth: 29.2%)
$27.40
(+115%)
Bear:
(PE: 7.2, Growth: 29.2%)
$23.29
(+83%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Forward PE: 12.02 | Forward EPS (Implied): $1.06
Bull Case
$15.36
(+21%)
Analyst growth 15.0%, PE expands to 12.6
Base Case
$12.72
(0%)
Market implied 0.0%, PE stable at 12.0
Bear Case
$9.73
(-24%)
Severe decline -15.0%, PE contracts to 10.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.4 to 8.8
Stabilization Target:
$13.25
(+4.2%)
PE Expansion Potential:
+4.2%
Share & Embed Analysis
Last updated: October 23, 2026 1:30 AM ET
Data refreshes hourly during market hours. Next update: 2:30 AM
Data refreshes hourly during market hours. Next update: 2:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$297 | 31 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$79 | 52 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$34 | 23 SELL |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$112 | 44 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 39 SELL |
Advanced PHR Option Strategies
Professional options setups generated by AI based on today's PHR price and gamma walls.
